首页> 美国卫生研究院文献>British Medical Journal >Body Composition Changes in Hypertensive Subjects on Long-term Oral Diuretic Therapy
【2h】

Body Composition Changes in Hypertensive Subjects on Long-term Oral Diuretic Therapy

机译:长期口服利尿剂治疗的高血压患者的身体成分变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hypertensive patients were treated with either chlorthalidone or frusemide for periods of two to four months. Reduction in blood pressure was seen with chlorthalidone but not with frusemide. This hypotensive effect appeared to be independent of the natriuretic effect.A significant reduction in total exchangeable potassium (KE) was seen with both agents, but no patient showed adverse symptoms or signs. There was no alteration in maximal urinary concentration or acidification, or in intravenous glucose tolerance or plasma insulin. It is concluded that potassium depletion of this degree does not require replacement therapy on a routine basis in hypertensive patients.
机译:高血压患者接受氯噻酮或氟硝胺治疗2-4个月。氯噻酮可降低血压,而氟硝胺则无。这种降压作用似乎与利尿钠作用无关。两种药物的总可交换钾(KE)均显着降低,但没有患者出现不良症状或体征。最大尿液浓度或酸化,静脉内葡萄糖耐量或血浆胰岛素没有改变。结论是,在高血压患者中,这种程度的钾耗竭不需要常规治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号